Hepion Pharmaceuticals (NASDAQ: HEPA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Hepion Pharmaceuticals (NASDAQ: HEPA) through any online brokerage.
The latest price target for Hepion Pharmaceuticals (NASDAQ: HEPA) was reported by Cantor Fitzgerald on Monday, February 28, 2022. The analyst firm set a price target for 3.50 expecting HEPA to rise to within 12 months (a possible 511.35% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.5725 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Hepion Pharmaceuticals.
Hepion Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.